Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease

Annals of Neurology

Volumn 47, Issue 2, 2000, Pages 201-210

  Solano, Steven M ^a   Miller, David W ^a   Augood, Sarah J ^a   Young, Anne B ^a   Penney Jr , John B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MESSENGER RNA; UBIQUITIN;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SUBSTANTIA NIGRA;

AGED; ALPHA-SYNUCLEIN; BASAL GANGLIA; BRAIN; DOPAMINE; FEMALE; HUMANS; LIGASES; MALE; MESENCEPHALON; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PROTEINS; REFERENCE VALUES; RNA, MESSENGER; SYNUCLEINS; TELENCEPHALON; THIOLESTER HYDROLASES; TISSUE DISTRIBUTION; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

EID: 0033961490     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F     Document Type: Article

References (49)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
2. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108 (Letter)
3. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608
4. Hattori N, Matsumine H, Asakawa S, et al. Point mutations (Thr240Arg and Ala311Stop) in the Parkin gene. Biochem Biophys Res Commun 1998;249:754-758
5. Lucking CB, Abbas N, Durr A, et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism: the European consortium on genetic susceptibility in Parkinson's disease and the French Parkinson's disease genetics study group. Lancet 1998; 352:1355-1356
6. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-892
7. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452
8. Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;21:249-254
9. Lavedan C. The synuclein family. Genet Res 1998;8:871-880
10. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic terminal. J Neurosci 1988;8:2804-2815
11. Maroteaux L, Scheller RH. The rat brain synucleins: family of proteins transiently associated with the neuronal membrane. Mol Brain Res 1991;11:335-343
12. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286
13. George J, Jin H, Woods W, et al. Characterization of a novel protein regulated during the critical period for song learning in rhe zebra finch. Neuron 1995;15:361-372
14. Spillantini MG, Schmidt ML, Lee VMY, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840
15. Irizarry M, Growdon J, Gomez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998;57:334-337
16. Sunada Y, Saito F, Matsumura K, et al. Differential expression of the parkin gene in the human brain and peripheral leukocytes. Neurosci Lett 1998;254:180-182
17. Doran JF, Jackson P, Kynoch PAM, et al. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem 1983; 40:1542-1547
18. Day INM, Thompson RJ. Molecular cloning of cDNA coding for human PGP 9.5 protein: A novel cytoplasmic marker for neurones and neuroendocrine cells. FEBS Lett 1987;210:157-160
19. Lowe J, McDermott H, Landon M, et al. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 1990;161:153-160
20. Day INM, Hinks LJ, Thompson RJ. The structure of the human gene encoding protein gene product 9.5 (PGP 9.5), a neuron specific ubiquitin C-terminal hydrolase. J Biochem 1990; 268:521-524
21. Wilkinson KD, Lee K, Deshpande S, et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989;246:670-673
22. Larsen CN, Krantz BA, Wilkinson KD. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998;37:3358-3368
23. Schofield JN, Day INM, Thompson RJ, et al. PGP 9.5, a ubiquitin C-terminal hydrolase: pattern of mRNA and protein expression during neural development in the mouse. Dev Brain Res 1995;85:229-238
24. Vonsattel JPG, Aizawa H, Ge P, et al. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 1995;54:42-56
25. Kingsbury AE, Foster OJF, Nisbet AP, et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol Brain Res 1995;28:311-318
26. Kerner J, Standaert DG, Penney JB Jr, et al. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Res Protocols 1998;3:22-32
27. Landwehrmeyer GB, Standaert DG, Testa CM, et al. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 1995;15:5297-5307
28. DeArmond S, Fusco M, Dewey M. Structure of the human brain: a photographic atlas. New York: Oxford University Press, 1989
29. Forno, LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-272
30. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124
31. Iseki E, Marui W, Kosaka K, et al. Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 1998;258:81-84
32. Dickson DW, Schmidt ML, Lee VMY, et al. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 1994;87:269-276
33. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147
34. Spillantini MG, Crowther RA, Jakes R, et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-208
35. Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44: 415-422
36. Arima K, Ueda K, Sunohara N, et al. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 1998;96:439-444
37. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998;96:445-452
38. Shimura H, Hattori N, Kubo S, et al. Immunohistochemical and subcellular localization of parkin protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol 1999;45: 668-672
39. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52: 183-191
40. Jensen PH, Nielsen MS, Jakes R, et al. Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998;273:26292-26294
41. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat Med 1998;4:1318-1320
42. Golbe, L. α-Synuclein and Parkinson's disease. Mov Disord 1999;14:6-9
43. Zareparsi S, Kay J, Camicioli R, et al. Analysis of the α-synuclein G209A mutation in familial Parkinson's disease. Lancet 1998;351:37-38
44. Chan P, Tanner CM, Jiang X, et al. Failure to find the a-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50: 513-514
45. Vaughan J, Durr A, Tassin J, et al. The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. Ann Neurol 1998;44: 270-273
46. Higuchi S, Arai H, Matsushita S, et al. Mutation in the α-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies. Exp Neurol 1998;153: 164-166
47. Weinreb PH, Zhen W, Poon AW, et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 1996;35:13709-13715
48. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993;16:439-444
49. Dexter DT, Sian J, Rose S, et al. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994;35:38-44